X0306 4 2020-11-02 0 0001800315 Galecto, Inc. GLTO 0001110780 GOLDFISCHER CARL C/O GALECTO, INC. OLE MAALOES VEJ 3 COPENHAGEN N G7 DK-2200 DENMARK 1 0 0 0 Common Stock 2020-11-02 4 C 0 9587 A 9587 D Common Stock 2020-11-02 4 C 0 1020036 A 1020036 I See footnote Common Stock 2020-11-02 4 C 0 19432 A 19432 I See footnote Series D Preferred Stock 2020-09-25 4 A 0 3688 27.11 A Common Stock 9587 3688 D Series C-3 Preferred Stock 2020-11-02 4 C 0 392367 0.00 D Common Stock 1020036 0 I See footnote Series C-3 Preferred Stock 2020-11-02 4 C 0 7475 0.00 D Common Stock 19432 0 I See footnote Series D Preferred Stock 2020-11-02 4 C 0 3688 0.00 D Common Stock 9587 0 D These shares are held by Bay City Capital Fund V, L.P. ("Fund V"). These shares are held by Bay City Capital Fund V Co-Investment Fund, L.P. ("Co-Investment V"). The Reporting Person is an Investment Partner and Managing Director of Bay City Capital LLC, the manager of Bay City Capital Management V LLC ("Management V"). Management V is the general partner of Fund V and Co-Investment V. The Reporting Person may be deemed to share voting, investment and dispositive power with respect to the shares held by Fund V and Co-Investment V. Dr. Goldfischer disclaims beneficial ownership of such securities, except to the extent of his indirect pecuniary interest therein. The Series C-3 Preferred Stock and Series D Preferred Stock (collectively, the "Preferred Stock") was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The Preferred Stock converted into Common Stock at a ratio of 2.59970:1 upon the closing of the Issuer's initial public offering without payment of additional consideration. The Preferred Stock had no expiration date. This transaction occurred prior to the Issuer's initial public offering and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3. /s/ Jonathan Freve, attorney-in-fact 2020-11-04